Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers.
Grossman I, Avidan N, Singer C, Goldstaub D, Hayardeny L, Eyal E, Ben-Asher E, Paperna T, Pe'er I, Lancet D, Beckmann JS, Miller A.
Grossman I, et al. Among authors: miller a.
Pharmacogenet Genomics. 2007 Aug;17(8):657-66. doi: 10.1097/FPC.0b013e3281299169.
Pharmacogenet Genomics. 2007.
PMID: 17622942
Clinical Trial.